FDA OKs use of Avastin for Breast Cancer

I wonder how much Genentech paid the FDA for this. They stand to make zillions from expanding the use of this toxic drug to breast cancer cases. We are going in the wrong direction!!!!

EXCERPT: In December, a panel of outside FDA advisers voted 5 to 4 against Genentech's application, indicating the drug's benefits did not outweigh toxic side effects. And it costs over $100,000 a year to use!
http://www.cbsnews.com/stories/2008/02/22/health/main3866827.shtml?source=RSSattr=Health_3866827